Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Carlos Gallardo Piqué
|
| gptkbp:country |
gptkb:Spain
|
| gptkbp:focusArea |
dermatology
medical aesthetics |
| gptkbp:founded |
1943
|
| gptkbp:founder |
Antonio Gallardo Carreras
|
| gptkbp:headquarters_location |
gptkb:Barcelona
|
| https://www.w3.org/2000/01/rdf-schema#label |
Almirall
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:netIncome |
€4.3 million (2022)
|
| gptkbp:notableAcquisition |
Aqua Pharmaceuticals
Tao Pharmaceuticals |
| gptkbp:numberOfEmployees |
~1800
|
| gptkbp:products |
respiratory medicines
dermatology medicines |
| gptkbp:revenue |
€878.5 million (2022)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:BME
|
| gptkbp:stockSymbol |
gptkb:ALM
|
| gptkbp:website |
https://www.almirall.com/
|
| gptkbp:bfsParent |
gptkb:dalbavancin
|
| gptkbp:bfsLayer |
6
|